# A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

> **NCT05713318** · PHASE2 · COMPLETED · sponsor: **Huahui Health** · enrollment: 200 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** HH-120 nasal spray
- **DRUG:** HH-120 nasal spray
- **DRUG:** Placebo Comparator
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT05713318
- **Lead sponsor:** Huahui Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-18
- **Primary completion:** 2023-06-19
- **Final completion:** 2023-06-19
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713318, "A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05713318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*